MacroGenics, Inc. (MGNX) - Wutah bathi EPS kuartalan

Tandha merek MacroGenics, Inc. (MGNX)

Quarterly EPS progress demonstrates the profit dynamics of MacroGenics, Inc. (MGNX), where -226.60 characterizes this valuation parameter. Current innovation expenses are outpacing revenues, but a liquid reserve supports operations. Antibody production is combined with the engagement of external partners for trials. Meanwhile, MacroGenics, Inc. (MGNX) strictly adheres to environmental standards, minimizing laboratory emissions and optimizing transport flows.

MacroGenics (MGNX) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan saka 04.07.2022 nganti 14.11.2026

Rincian analitis lan laporan data perusahaan MacroGenics Inc. (MGNX)

- nilai pasar lan prakiraan target analis:
Bagan rega MacroGenics|MGNX - Prakiraan gabungan firma investasi
- indikator kapitalisasi pasar:
Kapitalisasi pasar MacroGenics Corp|MGNX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- indikator nilai aset resik miturut neraca:
Nilai Buku saben Saham MacroGenics|MGNX - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku macrogenics.com|MGNX - Nilai Agregat Aset
- rincian utang lan likuiditas:
Utang marang Ekuitas MacroGenics, Inc.|MGNX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal MacroGenics, Inc.|MGNX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku MacroGenics Corp|MGNX - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan MacroGenics|Likuiditas cepet macrogenics.com
- indikator bathi lan kelipatan valuasi:
MGNX - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep MacroGenics, Inc.|MGNX - Rasio kapitalisasi marang bathi resik|Pangali Forward P/E MacroGenics Corp|MGNX - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MacroGenics Corp|MGNX - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) MacroGenics|MGNX - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan macrogenics.com|MGNX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MacroGenics, Inc.
- indikator volume dodolan lan pendapatan:
MGNX - Pendapatan reged perusahaan|Volume dodolan mangsa ngarep perusahaan MacroGenics|MGNX - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S MacroGenics Corp
Analisis wiwitan perusahaan:MacroGenics - MGNX
Produk asil prodhuksi MacroGenics Inc.

This indicator measures the percentage change in earnings per share between the current and corresponding previous quarter, allowing for an assessment of the real profitability dynamics of MacroGenics, Inc. (MGNX). By analyzing the quarterly EPS growth trend, an investor can see the impact of licensing payments and the success of the DART platform, where profit growth rates confirm the commercial efficiency of developing drugs against metastatic cancer.

Pesaing utama

Olema (OLMA) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan PBYI|GLSI (Greenwich LifeSciences, Inc) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Zentalis Pharma (ZNTL)|Wutah bathi EPS kuartalan PSTV|PCSA - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Eagle Pharmaceuticals, Inc. EGRX